BrightEdge - American Cancer Society

📢 The ACS BrightEdge 2024 Annual Report is live! At BrightEdge, the innovation and impact investing arm of the American Cancer Society, we are committed to investing in and scaling innovations that advance the fight against cancer. Since our launch, we’ve invested $52M in 22 companies advancing breakthroughs across the cancer care continuum. Today we release our 2024 Annual Impact Report showcasing the breadth of innovation programs, impact tools, and investments that support the development of cutting-edge therapies, diagnostics, and technologies with the potential to benefit millions of patients and their families. We invite you to partner with us to advance the next generation of cancer solutions. 📖 Read the full report: https://lnkd.in/e_5dh7vN #ImpactInvesting #CancerInnovation #ACS #BrightEdge

🚨 Mentor Monday Alert!! 🚨    On this #MentorMonday we’re shining a spotlight on 3 amazing Mentors participating in the 2025 BrightEdge Entrepreneurs (BEE) program: Susanne Somerville, Debra Chao, and Ozge Kurtoglu. We sincerely appreciate each of our Mentors for their time, dedication, and invaluable guidance in supporting the Entrepreneurs in the program. Stay tuned for our upcoming posts as we introduce more of our incredible mentors!     For inquiries about the BEE program, please reach out to Farnaz Bakhshi or Bianca Scimemi. The BEE Program is generously supported and made possible by the WoodNext Foundation, a donor advised fund sponsored by the Greater Houston Community Foundation. A BIG thank you to our leading sponsor Persephoni Bio, and to our sponsors, Wilson Sonsini Goodrich & Rosati, BostonGene, Charles River Laboratories, Foley Hoag LLP, Mercury, Edward Jones, for supporting the BEE Program! Let's ignite innovation and entrepreneurship together! 💡🚀

Excited to share an upcoming opportunity for life sciences and healthtech companies and investors! Orrick and friends are hosting a half-day summit in San Francisco on Wednesday, October 8th where we will explore the latest financing strategies for life sciences and healthtech companies! Hear from industry leaders on:   • State of the Market • Royalty & Debt Financing • Build-to-Buy Partnerships • Philanthropy in Life Sciences • State Funding   If interested, please contact nyankellow@orrick.com to learn more. Jennifer Friel Goldstein | Ashwin Pai | Matt Rizzo | Kiran Reddy | Stephen Thau | Joe Heanue | Jason Yip | John Pennett | Alice Lin Pomponio | Lisa Suennen | Norman Friedland, Esq. | Jonathan Thomas | Thora Johnson     #LifeSciences #HealthTech #Innovation #Networking

Headed to #MedTech2025 in San Diego this week! Our Managing Director, Alice Lin Pomponio, will be joining the AdvaMed Accel Leadership Seminar: Finding the Path Forward – Alternative Sources of Financing for Medtech Innovation alongside Stephen Thau, Jarret Fass, Kylle Jordan, and Joe Heanue. The panel will highlight how alternative financing models from venture capital to mission-driven impact investing can accelerate medtech innovation and bring life-changing technologies to patients faster. That’s exactly what BrightEdge, the American Cancer Society’s innovation and impact investment arm, strive to do every day. Looking forward to the conversation and to connecting with others advancing progress in health innovation. #MedTech2025 #ImpactInvesting #HealthTechInnovation

🚀 BrightEdge is pleased to announce its investment in Predicta Biosciences Biosciences, advancing the ACS mission priority to develop novel biomedical products, specifically therapeutics and diagnostics that provide innovative approaches to treat cancer.    Predicta is developing non-invasive diagnostics for multiple myeloma and other blood cancers, hoping to give physicians the insights they need to match patients with the right therapies, faster.   By supporting Predicta, BrightEdge is fueling a future where precision diagnostics and therapeutics work hand-in-hand to transform cancer care to improve outcomes for patients facing blood cancers and autoimmune conditions.

🚨It’s Trailblazer Thursday!! 🚨    🌟 Meet this week's #TrailblazerThursday spotlight: Michael Girardi, MD, physician, scientist, and Founder/CSO of Artelis 🚀  For inquiries about the BEE program, please reach out to Farnaz Bakhshi or Bianca Scimemi.    The BEE Program is generously supported and made possible by the the WoodNext Foundation, a donor advised fund sponsored by the the Greater Houston Community Foundation.   A BIG thank you to our leading sponsor Persephoni Bio, and to our sponsors, Wilson Sonsini Goodrich & Rosati, BostonGene, Charles River Laboratories, Foley Hoag LLP, Mercury, Edward Jones, for supporting the BEE Program!    Let's ignite innovation and entrepreneurship together! 💡🚀     #BEEProgram #TrailblazerThursday #Entrepreneurship #Innovation #CancerResearch #AmericanCancerSociety #Brightedge  

🌟 A new opportunity is here for bold founders!     The American Cancer Society’s BrightEdge Entrepreneurs Program is expanding with two dedicated tracks:    🔬 Life Sciences  💻 Digital Health    We listened to feedback from founders, partners and advisors—and evolved to make the program more focused, strategic and impactful.     Participants will gain:  ✨ Investment from BrightEdge  📚 Monthly educational sessions  🤝 Access to a robust mentor network  🌐 Connectivity to ACS BrightEdge and ScaleHealth ecosystems    This evolution means we’re even better positioned to turn bold ideas into real-world solutions that improve cancer care and health outcomes for all.     📅 Applications for both tracks are OPEN NOW—don’t miss your chance to shape the future of cancer innovation! https://lnkd.in/e6BEjiv6   ❓Questions❓ Please reach out to contact@scalehealth.com    A generous thank you to our leading sponsor, Persephoni Bio.   If you’d like to learn more about how to engage with us, we’d love to hear from you—reach out anytime!  Farnaz Bakhshi, Stephen Curtis, Bianca Scimemi, Nate Macht, Alice Lin Pomponio, Adam Glasofer, MD, MSHI, Carol Curtis, Ph.D., Taylor McPartland,  Kelly Chu, Chris Spearman, India Williams, Kat Karimi, Johnny Lam, Piya Mann.

🚨It’s Trailblazer Thursday!! 🚨    🌟 Meet this week's #TrailblazerThursday spotlight: Carole Spangler Vaughn, PhD, MBA , inventor, founder and CEO of Eisana Corp 🚀  For inquiries about the BEE program, please reach out to Farnaz Bakhshi or Bianca Scimemi.    The BEE Program is generously supported and made possible by the the WoodNext Foundation, a donor advised fund sponsored by the the Greater Houston Community Foundation.   A BIG thank you to our leading sponsor Persephoni Bio, and to our sponsors, Wilson Sonsini Goodrich & Rosati, BostonGene, Charles River Laboratories, Foley Hoag LLP, Mercury, Edward Jones, for supporting the BEE Program!    Let's ignite innovation and entrepreneurship together! 💡🚀     #BEEProgram #TrailblazerThursday #Entrepreneurship #Innovation #CancerResearch #AmericanCancerSociety #Brightedge  

🚨 Mentor Monday Alert!! 🚨    On this #MentorMonday we’re shining a spotlight on 5 amazing Mentors participating in the 2025 BrightEdge Entrepreneurs (BEE) program: Veronica Gibaja, Kate Wolin, Robert Gottlieb, and Jill Collins, PhD. We sincerely appreciate each of our Mentors for their time, dedication, and invaluable guidance in supporting the Entrepreneurs in the program. Stay tuned for our upcoming posts as we introduce more of our incredible mentors!     For inquiries about the BEE program, please reach out to Farnaz Bakhshi or Bianca Scimemi.   The BEE Program is generously supported and made possible by the the WoodNext Foundation, a donor advised fund sponsored by the Greater Houston Community Foundation. A BIG thank you to our leading sponsor Persephoni Bio, and to our sponsors, Wilson Sonsini Goodrich & Rosati, BostonGene, Charles River Laboratories, Foley Hoag LLP, Mercury, and Edward Jones, for supporting the BEE Program! Let's ignite innovation and entrepreneurship together! 💡🚀

🚀 Teaching Tuesday Alert! 🚀     BrightEdge Entrepreneurs (BEE) program is excited to present an educational session exploring key insights and strategies related to Clinical Trials with Frank S. David. Dr. David is the Founder & Managing Director of Pharmagellan, where he partners with both emerging and established biomedical companies, entrepreneurs, and investors to unlock the full potential of innovative R&D. With deep expertise across the life sciences sector—including biopharma, medical devices, diagnostics, research tools, and health care services—Dr. David has advised leaders in R&D, business development, and investment communities across a wide range of indications. The BEE Program is generously supported and made possible by the the WoodNext Foundation, a donor advised fund sponsored by the Greater Houston Community Foundation. A BIG thank you to our leading sponsor Persephoni Bio, and to our sponsors, Wilson Sonsini Goodrich & Rosati, BostonGene, Charles River Laboratories, Foley Hoag LLP, Mercury, and Edward Jones, for supporting the BEE Program! For inquiries about the BEE program, please reach out to Farnaz Bakhshi or Bianca Scimemi. #BEEProgram #TeachingTuesday #Entrepreneurship #Innovation #CancerResearch #AmericanCancerSociety #Brightedge     Let's ignite innovation and entrepreneurship together! 💡🚀